Table 3 Description of person characteristics with at least one consultation with physiotherapists and dentists during the lockdown periods and the whole of 2020 relative to the corresponding periods in 2019, for mainland France
Physiotherapist | Dentist | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
At least one consultation 2020 | Ratio 2020/2019 | At least one consultation 2020 | Ratio 2020/2019 | ||||||||||
Individuals | LD 1 | LD 2 | Year | LD 1 | LD 2 | Year | LD 1 | LD 2 | Year | LD 1 | LD 2 | Year | |
2020 Million | % | % | % | % | % | % | % | % | % | % | % | % | |
Total | 64.3 | 1.6 | 6.7 | 15.2 | -80 | -3 | -8 | 0.5 | 9.8 | 37.1 | -95 | 1 | -12 |
Age (years) | |||||||||||||
0–1 | 1.4 | 0.6 | 1.1 | 7.0 | -86 | -44 | -44 | 0.0 | 0.5 | 1.7 | -95 | -3 | -14 |
2–6 | 3.7 | 0.1 | 0.5 | 1.2 | -83 | -11 | -24 | 0.2 | 7.1 | 29.9 | -97 | -5 | -13 |
7–17 | 8.4 | 0.3 | 2.4 | 6.2 | -89 | -9 | -17 | 0.9 | 9.2 | 40.1 | -92 | 0 | -15 |
18–25 | 5.8 | 0.5 | 3.0 | 8.5 | -86 | + 2 | -7 | 0.4 | 6.9 | 30.5 | -95 | + 8 | -12 |
26–50 | 20.0 | 1.1 | 6.1 | 14.5 | -84 | 0 | -9 | 0.6 | 10.6 | 39.1 | -95 | + 4 | -13 |
51–65 | 12.2 | 2.0 | 9.1 | 20.0 | -81 | -2 | -7 | 0.6 | 12.3 | 42.8 | -96 | 0 | -11 |
66–75 | 6.9 | 2.5 | 10.2 | 22.7 | -79 | -5 | -6 | 0.5 | 11.6 | 41.3 | -96 | 0 | -9 |
76–85 | 4.2 | 4.5 | 13.5 | 27.9 | -72 | -7 | -7 | 0.4 | 8.8 | 33.8 | -96 | -5 | -11 |
> 85 | 1.8 | 8.6 | 16.6 | 31.0 | -57 | -2 | -1 | 0.2 | 4.0 | 18.0 | -97 | -8 | -12 |
Sex | |||||||||||||
Male | 30.7 | 1.3 | 5.1 | 12.5 | -79 | -3 | -9 | 0.5 | 9.0 | 34.4 | -95 | + 1 | -12 |
Female | 33.5 | 1.9 | 8.1 | 17.7 | -80 | -3 | -8 | 0.5 | 10.5 | 39.6 | -95 | + 1 | -12 |
Geographic deprivation index (quintile) | |||||||||||||
Q1(Most favored) | 12.6 | 1.7 | 7.4 | 16.3 | -80 | -3 | -7 | 0.5 | 10.6 | 40.7 | -95 | + 3 | -11 |
Q2 | 12.9 | 1.8 | 7.4 | 16.6 | -80 | -2 | -8 | 0.5 | 10.3 | 38.8 | -95 | + 2 | -12 |
Q3 | 12.9 | 1.7 | 7.1 | 16.1 | -79 | -2 | -8 | 0.5 | 9.9 | 37.5 | -95 | + 1 | -12 |
Q4 | 12.6 | 1.5 | 6.2 | 14.4 | -79 | -4 | -9 | 0.6 | 9.4 | 35.4 | -95 | -1 | -13 |
Q5 (Least favored) | 12.2 | 1.4 | 5.4 | 12.6 | -79 | -5 | -10 | 0.5 | 8.8 | 33.1 | -95 | -2 | -14 |
Covid-19 hospitalization rate, LD 1 | |||||||||||||
Q1a < 54.8 | 11.3 | 1.8 | 7.2 | 16.5 | -79 | -2 | -8 | 0.5 | 10.0 | 37.6 | -95 | 0 | -13 |
Q2 54.8–88.1 | 15.4 | 1.9 | 7.5 | 16.9 | -78 | -2 | -8 | 0.5 | 9.8 | 37.4 | -95 | + 1 | -12 |
Q3 88.1–178.1 | 13.3 | 1.8 | 6.7 | 15.1 | -78 | -4 | -9 | 0.6 | 9.5 | 35.7 | -95 | -1 | -14 |
Q4 > 178.1 | 24.0 | 1.3 | 5.9 | 13.5 | -82 | -4 | -8 | 0.5 | 9.9 | 37.5 | -95 | + 3 | -11 |
Covid-19 hospitalization rate, 2020 | |||||||||||||
Q1a < 233.2 | 12.9 | 1.8 | 7.3 | 16.5 | -79 | -1 | -8 | 0.5 | 10.0 | 37.7 | -96 | + 1 | -13 |
Q2 233.2–352.8 | 13.6 | 1.9 | 7.3 | 16.5 | -78 | -3 | -8 | 0.6 | 9.8 | 36.9 | -95 | + 1 | -13 |
Q3 352.8–511.0 | 17.8 | 1.6 | 6.2 | 14.0 | -78 | -5 | -9 | 1.6 | 9.4 | 35.7 | -95 | 0 | -13 |
Q4 511.0 and above | 19.9 | 1.3 | 6.3 | 14.5 | -82 | -3 | -8 | 1.3 | 10.1 | 38.2 | -95 | + 2 | -11 |